Cargando…
Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine
IMPORTANCE: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and oral HPV infection is associated with increased risk of oropharyngeal cancer. OBJECTIVE: To describe the risk factors for oral HPV in sexually active female adolescents receiving the qu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822084/ https://www.ncbi.nlm.nih.gov/pubmed/31651968 http://dx.doi.org/10.1001/jamanetworkopen.2019.14031 |
_version_ | 1783464268113379328 |
---|---|
author | Schlecht, Nicolas F. Masika, Martin Diaz, Angela Nucci-Sack, Anne Salandy, Anthony Pickering, Sarah Strickler, Howard D. Shankar, Viswanathan Burk, Robert D. |
author_facet | Schlecht, Nicolas F. Masika, Martin Diaz, Angela Nucci-Sack, Anne Salandy, Anthony Pickering, Sarah Strickler, Howard D. Shankar, Viswanathan Burk, Robert D. |
author_sort | Schlecht, Nicolas F. |
collection | PubMed |
description | IMPORTANCE: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and oral HPV infection is associated with increased risk of oropharyngeal cancer. OBJECTIVE: To describe the risk factors for oral HPV in sexually active female adolescents receiving the quadrivalent vaccine. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal cohort study involving repeated collection of oral rinse specimens from sexually active female adolescents conducted between October 19, 2007, and March 9, 2017, at a large adolescent health center in New York, New York, that provides free health care, including HPV vaccination. EXPOSURES: Human papillomavirus vaccination and self-reported history of sexual behavior. MAIN OUTCOMES AND MEASURES: Prevalence of HPV in the oral cavity. RESULTS: Among the 1259 participants who were included in this study, median age at entry into the study was 18 (range, 13-21) years; 638 (50.7%) were of African American descent, 569 (45.2%) were of Hispanic descent, 43 (3.4%) reported another race/ethnicity, and race/ethnicity was unspecified for 9 (0.7%). The median (mode) age at first sexual activity was 14.8 (14) years, and 1161 (92.2%) reported having had oral sex. Human papillomavirus DNA was detected in baseline oral rinse samples of 78 of the 1259 participants (6.2%; 95% CI, 4.9%-7.6%). There was a significant decrease in oral HPV detection with time (in years) since first engaging in sexual activities, independent of age and concurrent detection of cervical HPV; comparing 4 or more years with 1 year or less, the odds ratio was 0.45 (95% CI, 0.21-0.96). Detection of vaccine types (HPV-6, HPV-11, HPV-16, and HPV-18) was significantly lower among participants who had received at least 1 dose of the quadrivalent HPV vaccine at the time of enrollment compared with those who were unvaccinated (odds ratio, 0.20; 95% CI, 0.04-0.998). CONCLUSIONS AND RELEVANCE: This study’s findings suggest that detection of HPV in the oral cavity is not uncommon in sexually active female adolescents. In addition, HPV vaccination is associated with a significant decrease in detection of HPV vaccine types in the oral cavity. |
format | Online Article Text |
id | pubmed-6822084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-68220842019-11-14 Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine Schlecht, Nicolas F. Masika, Martin Diaz, Angela Nucci-Sack, Anne Salandy, Anthony Pickering, Sarah Strickler, Howard D. Shankar, Viswanathan Burk, Robert D. JAMA Netw Open Original Investigation IMPORTANCE: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and oral HPV infection is associated with increased risk of oropharyngeal cancer. OBJECTIVE: To describe the risk factors for oral HPV in sexually active female adolescents receiving the quadrivalent vaccine. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal cohort study involving repeated collection of oral rinse specimens from sexually active female adolescents conducted between October 19, 2007, and March 9, 2017, at a large adolescent health center in New York, New York, that provides free health care, including HPV vaccination. EXPOSURES: Human papillomavirus vaccination and self-reported history of sexual behavior. MAIN OUTCOMES AND MEASURES: Prevalence of HPV in the oral cavity. RESULTS: Among the 1259 participants who were included in this study, median age at entry into the study was 18 (range, 13-21) years; 638 (50.7%) were of African American descent, 569 (45.2%) were of Hispanic descent, 43 (3.4%) reported another race/ethnicity, and race/ethnicity was unspecified for 9 (0.7%). The median (mode) age at first sexual activity was 14.8 (14) years, and 1161 (92.2%) reported having had oral sex. Human papillomavirus DNA was detected in baseline oral rinse samples of 78 of the 1259 participants (6.2%; 95% CI, 4.9%-7.6%). There was a significant decrease in oral HPV detection with time (in years) since first engaging in sexual activities, independent of age and concurrent detection of cervical HPV; comparing 4 or more years with 1 year or less, the odds ratio was 0.45 (95% CI, 0.21-0.96). Detection of vaccine types (HPV-6, HPV-11, HPV-16, and HPV-18) was significantly lower among participants who had received at least 1 dose of the quadrivalent HPV vaccine at the time of enrollment compared with those who were unvaccinated (odds ratio, 0.20; 95% CI, 0.04-0.998). CONCLUSIONS AND RELEVANCE: This study’s findings suggest that detection of HPV in the oral cavity is not uncommon in sexually active female adolescents. In addition, HPV vaccination is associated with a significant decrease in detection of HPV vaccine types in the oral cavity. American Medical Association 2019-10-25 /pmc/articles/PMC6822084/ /pubmed/31651968 http://dx.doi.org/10.1001/jamanetworkopen.2019.14031 Text en Copyright 2019 Schlecht NF et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Schlecht, Nicolas F. Masika, Martin Diaz, Angela Nucci-Sack, Anne Salandy, Anthony Pickering, Sarah Strickler, Howard D. Shankar, Viswanathan Burk, Robert D. Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine |
title | Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine |
title_full | Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine |
title_fullStr | Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine |
title_full_unstemmed | Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine |
title_short | Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine |
title_sort | risk of oral human papillomavirus infection among sexually active female adolescents receiving the quadrivalent vaccine |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822084/ https://www.ncbi.nlm.nih.gov/pubmed/31651968 http://dx.doi.org/10.1001/jamanetworkopen.2019.14031 |
work_keys_str_mv | AT schlechtnicolasf riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine AT masikamartin riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine AT diazangela riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine AT nuccisackanne riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine AT salandyanthony riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine AT pickeringsarah riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine AT stricklerhowardd riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine AT shankarviswanathan riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine AT burkrobertd riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine |